Learn more

EMISPHERE TECH INC

Overview
  • Total Patents
    825
  • GoodIP Patent Rank
    94,541
  • Filing trend
    ⇩ 25.0%
About

EMISPHERE TECH INC has a total of 825 patent applications. It decreased the IP activity by 25.0%. Its first patent ever was published in 1987. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are THERMOLIFE INTERNATIONAL LLC, Nabriva Therapeutics GmbH and CHANGZHOU SUNLIGHT PHARM CO LTD.

Patent filings per year

Chart showing EMISPHERE TECH INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Leone-Bay Andrea 232
#2 Milstein Sam J 182
#3 Gschneidner David 140
#4 Majuru Shingai 119
#5 Sarubbi Donald J 99
#6 Ho Koc-Kan 78
#7 Dinh Steven 67
#8 Wang Nai Fang 64
#9 Tang Pingwah 57
#10 Wang Eric 51

Latest patents

Publication Filing date Title
BR112015003761A2 compound, pharmaceutical composition, dosage unit form, method for administering a biologically active agent and method for preparing a composition
AU2012202419A1 Aryl ketone compounds and compositions for delivering active agents
AU2012200214A1 Compounds and compositions for delivering active agents
EA026713B1 Solid oral dosage form for treating iron deficiency or anemia and use thereof
MX2012009914A Oral b12 therapy.
WO2011017346A2 Fast-acting naproxen composition with reduced gastrointestinal effects
WO2009100245A1 Low dose hmg-coa reductase inhibitor with reduced side effects
US2009124639A1 valacyclovir formulations
CA2704780A1 Method of treating vitamin b12 deficiency
CA2680737A1 Allyloxy and alkyloxy benzoic acid delivery agents
US2008146509A1 Compositions for delivering parathyroid hormone and calcitonin
CA2678575A1 Compounds having a cyclic moiety and compositions for delivering active agents
BRPI0807285A2 "COMPOSITION, METHOD FOR PREPARING PHARMACEUTICAL COMPOSITION, UNIT FORM OF DOSAGE, METHOD FOR ADMINISTRATING A BIOLOGICAL ACTIVE AGENT NEEDING THE AGENT, METHOD FOR INCREASING BIODISPONABILITY FOR PREPARING AN AGENT OF COMPOSITION"
WO2008070543A1 Improved acyclovir formulations
US2008095837A1 Human growth hormone formulations
AU2007293916A1 A process for the manufacture of SNAC (salcaprozate sodium)
CA2662853A1 Compounds and compositions for delivering active agents
EP2053918A2 Propyl phenoxy ethers for use as delivery agents
CA2672267A1 Arylsulfanyl compounds and compositions for delivering active agents
WO2008014232A2 Pharmaceutical formulations for the treatment of alzheimer's disease